These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 7673616

  • 1. Evaluation of the effect of lansoprazole in suppressing acid secretion using 24-hour intragastric pH monitoring.
    Takeda H, Hokari K, Asaka M.
    J Clin Gastroenterol; 1995; 20 Suppl 1():S7-9. PubMed ID: 7673616
    [Abstract] [Full Text] [Related]

  • 2. Comparison of lansoprazole and famotidine for gastric acid inhibition during the daytime and night-time in different CYP2C19 genotype groups.
    Shirai N, Furuta T, Xiao F, Kajimura M, Hanai H, Ohashi K, Ishizaki T.
    Aliment Pharmacol Ther; 2002 Apr; 16(4):837-46. PubMed ID: 11929404
    [Abstract] [Full Text] [Related]

  • 3. Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
    Sakaguchi M, Ashida K, Umegaki E, Miyoshi H, Katsu K.
    J Clin Gastroenterol; 1995 Apr; 20 Suppl 2():S27-31. PubMed ID: 7594334
    [Abstract] [Full Text] [Related]

  • 4. Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole.
    Katz PO, Hatlebakk JG, Castell DO.
    Aliment Pharmacol Ther; 2000 Jun; 14(6):709-14. PubMed ID: 10848653
    [Abstract] [Full Text] [Related]

  • 5. Effect of concomitant dosing of famotidine with lansoprazole on gastric acid secretion in relation to CYP2C19 genotype status.
    Furuta T, Shirai N, Sugimoto M, Nakamura A, Okudaira K, Kajimura M, Hishida A.
    Aliment Pharmacol Ther; 2005 Jul 01; 22(1):67-74. PubMed ID: 15963082
    [Abstract] [Full Text] [Related]

  • 6. Acid-inhibitory effects of omeprazole and lansoprazole in Helicobacter pylori-negative healthy subjects.
    Geus WP, Mulder PG, Nicolai JJ, Van den Boomgaard DM, Lamers CB.
    Aliment Pharmacol Ther; 1998 Apr 01; 12(4):329-35. PubMed ID: 9690721
    [Abstract] [Full Text] [Related]

  • 7. Time to maximum effect of lansoprazole on gastric pH in normal male volunteers.
    Bell NJ, Hunt RH.
    Aliment Pharmacol Ther; 1996 Dec 01; 10(6):897-904. PubMed ID: 8971286
    [Abstract] [Full Text] [Related]

  • 8. Effect of four lansoprazole dose levels and one dosage regimen of omeprazole on 24-hour intragastric pH in healthy subjects.
    Timmer W, Ripke H, Kleist P, Ehrlich A, Wieckhorst G, Lücker PW, Fuder H.
    Methods Find Exp Clin Pharmacol; 1995 Sep 01; 17(7):489-95. PubMed ID: 8577212
    [Abstract] [Full Text] [Related]

  • 9. The comparative effects of lansoprazole, omeprazole, and ranitidine in suppressing gastric acid secretion.
    Blum RA, Shi H, Karol MD, Greski-Rose PA, Hunt RH.
    Clin Ther; 1997 Sep 01; 19(5):1013-23. PubMed ID: 9385488
    [Abstract] [Full Text] [Related]

  • 10. Effects of rabeprazole, lansoprazole and omeprazole on intragastric pH in CYP2C19 extensive metabolizers.
    Saitoh T, Fukushima Y, Otsuka H, Hirakawa J, Mori H, Asano T, Ishikawa T, Katsube T, Ogawa K, Ohkawa S.
    Aliment Pharmacol Ther; 2002 Oct 01; 16(10):1811-7. PubMed ID: 12269976
    [Abstract] [Full Text] [Related]

  • 11. Morning versus evening dosing of lansoprazole 30 mg daily on twenty-four-hour intragastric acidity in healthy subjects.
    Fraser AG, Sawyerr AM, Hudson M, Smith MS, Pounder RE.
    Aliment Pharmacol Ther; 1996 Aug 01; 10(4):523-7. PubMed ID: 8853755
    [Abstract] [Full Text] [Related]

  • 12. Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion and serum gastrin in healthy volunteers.
    Bruley des Varannes S, Levy P, Lartigue S, Dellatolas F, Lemaire M, Galmiche JP.
    Aliment Pharmacol Ther; 1994 Jun 01; 8(3):309-14. PubMed ID: 7918926
    [Abstract] [Full Text] [Related]

  • 13. Acid suppression in healthy subjects following lansoprazole or pantoprazole.
    Huang JQ, Goldwater DR, Thomson AB, Appelman SA, Sridhar S, James CF, Chiu YL, Pilmer BL, Keith RG, Hunt RH.
    Aliment Pharmacol Ther; 2002 Mar 01; 16(3):425-33. PubMed ID: 11876695
    [Abstract] [Full Text] [Related]

  • 14. Determining the optimal dose of lansoprazole injection by 24-hour intragastric pH monitoring.
    Sugiyama M, Aoki T, Matsuo Y.
    J Clin Gastroenterol; 1995 Mar 01; 20 Suppl 2():S14-6. PubMed ID: 7594331
    [Abstract] [Full Text] [Related]

  • 15. Effects of omeprazole and lansoprazole on 24-hour intragastric pH in Helicobacter pylori-positive volunteers.
    Verdú EF, Fraser R, Armstrong D, Blum AL.
    Scand J Gastroenterol; 1994 Dec 01; 29(12):1065-9. PubMed ID: 7886393
    [Abstract] [Full Text] [Related]

  • 16. Initial and chronic gastric acid inhibition by lansoprazole and omeprazole in relation to meal administration.
    Brummer RJ, Geerling BJ, Stockbrügger RW.
    Dig Dis Sci; 1997 Oct 01; 42(10):2132-7. PubMed ID: 9365148
    [Abstract] [Full Text] [Related]

  • 17. Acid-suppressive efficacy of a reduced dosage of rabeprazole: comparison of 10 mg twice daily rabeprazole with 20 mg twice daily rabeprazole, 30 mg twice daily lansoprazole, and 20 mg twice daily omeprazole by 24-hr intragastric pH-metry.
    Shimatani T, Inoue M, Kuroiwa T, Xu J, Tazuma S, Horikawa Y, Nakamura M.
    Dig Dis Sci; 2005 Jul 01; 50(7):1202-6. PubMed ID: 16047460
    [Abstract] [Full Text] [Related]

  • 18. The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs.
    Uchiyama K, Wakatsuki D, Kakinoki B, Takeuchi Y, Araki T, Morinaka Y.
    J Pharm Pharmacol; 1999 Apr 01; 51(4):457-64. PubMed ID: 10385219
    [Abstract] [Full Text] [Related]

  • 19. Differences in the antisecretory actions of the proton pump inhibitor AG-1749 (lansoprazole) and the histamine H2-receptor antagonist famotidine in rats and dogs.
    Nagaya H, Inatomi N, Satoh H.
    Jpn J Pharmacol; 1991 Apr 01; 55(4):425-36. PubMed ID: 1886288
    [Abstract] [Full Text] [Related]

  • 20. [Effects of intravenous lansoprazole on acute gastric mucosal lesions and acid secretion].
    Inatomi N, Murakami I, Asano S, Inada I, Satoh H.
    Nihon Yakurigaku Zasshi; 1996 Dec 01; 108(6):333-43. PubMed ID: 9017687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.